A61K 31/515
Barbituric acids
Official title: Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
A61K31/515 (Barbituric acids) appears on 288 US grants and 450 published applications in this corpus.
Search patents in A61K- Granted patents
- 288
- Published applications
- 450
- Assignees
- 211
- Inventors
- 675
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 12 | 0 |
| 2000 | 1 | 0 |
| 2001 | 8 | 1 |
| 2002 | 4 | 2 |
| 2003 | 0 | 6 |
| 2004 | 2 | 14 |
| 2005 | 2 | 9 |
| 2006 | 1 | 12 |
| 2007 | 4 | 13 |
| 2008 | 3 | 15 |
| 2009 | 1 | 11 |
| 2010 | 7 | 19 |
| 2011 | 4 | 8 |
| 2012 | 16 | 16 |
| 2013 | 7 | 16 |
| 2014 | 14 | 22 |
| 2015 | 13 | 28 |
| 2016 | 16 | 29 |
| 2017 | 19 | 40 |
| 2018 | 18 | 19 |
| 2019 | 14 | 20 |
| 2020 | 15 | 33 |
| 2021 | 13 | 26 |
| 2022 | 14 | 26 |
| 2023 | 19 | 25 |
| 2024 | 15 | 13 |
| 2025 | 10 | 12 |
| 2026 | 10 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bacterial DNA gyrase inhibitors and methods of use thereof25 Aug 2026US 12,714,692 B2The Florida International University Board of Trustees
- Indole molecules and use thereof in the inhibition of DNA polymerases21 Jul 2026US 12,685,733 B2BioVentures, LLC
- Lyophilized compositions of phenobarbital sodium salt30 Jun 2026US 12,667,545 B2Nivagen Pharmaceuticals, Inc.
- Stabilization of phenobarbital sodium for injection26 May 2026US 12,636,254 B2Sun Pharma Advanced Research Company Ltd.
- Treatment of viral infections, of organ injury, and of related conditions using a HIF prolyl hydroxylase inhibitor or a HIF-alpha stabilizer19 May 2026US 12,629,357 B2Akebia Therapeutics, Inc.
- Diffusion resistance layer for analyte sensors8 Oct 2026US 2026/0309670 A1DexCom, Inc.
- New e3 ubiquitin ligase ligand, protein degradation agent and use thereof17 Sep 2026US 2026/0274829 A1Gluetacs Therapeutics (Shanghai) Co., Ltd.
- Irhom2 inhibitors and uses thereof20 Aug 2026US 2026/0242359 A1New York Society for the Relief of the Ruptured and Crippled, Maintaing the Hospital for Special
- Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy30 Jul 2026US 2026/0216136 A1SK Biopharmaceuticals Co., Ltd.
- Potassium channel blockers or derivatives thereof for preventing, alleviating, and/or treating morbidity and mortality induced by pathogens or other inducers of immune exhaustion and/or excess immune activati30 Jul 2026US 2026/0216154 A1University of Rochester
Most cited
By later US patents
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Abuse-proofed dosage form249US 8,114,383 B2Gruenenthal GmbH · 2012
- Abuse-proofed dosage form205US 8,309,060 B2GrüNenthal GmbH · 2012
- Antiviral method, agents and apparatus95US 4,915,683 AThe Medical College of Wisconsin, Inc. · 1990
- Pain-alleviating drug composition and method for alleviating pain91US 5,840,731 AVirginia Commonwealth University · 1998